Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering

Go back to Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering
GALECTIN (NASDAQ: GALT) Delayed: 4.41 -0.07 (1.56%)
Previous Close $4.48    52 Week High $3.05 
Open $4.50    52 Week Low $0.49 
Day High $4.60    P/E N/A 
Day Low $4.34    EPS $-1.32 
Volume 115,020